Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
19.02
0.60 (3.26%)
At close: May 12, 2025, 3:59 PM
19.01
-0.05%
After-hours: May 12, 2025, 04:02 PM EDT
3.26% (1D)
| Bid | 14 |
| Market Cap | 933.24M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -89.02M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -10.06 |
| Forward PE | -7.25 |
| Analyst | Buy |
| Ask | 19.95 |
| Volume | 396,322 |
| Avg. Volume (20D) | 269,896 |
| Open | 19.24 |
| Previous Close | 18.42 |
| Day's Range | 18.61 - 19.85 |
| 52-Week Range | 13.30 - 30.03 |
| Beta | 1.10 |
About ELVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+6.02%
Enliven Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription